Valsartan Tablet — FDA Drug Shortage

To Be Discontinued — Mylan Pharmaceuticals Inc., A Viatris Company

The FDA lists a drug shortage record for Valsartan Tablet (tablet) from Mylan Pharmaceuticals Inc., A Viatris Company with status To Be Discontinued. The shortage was first posted on Nov 19, 2025.

Shortage details

Status
To Be Discontinued
Company
Mylan Pharmaceuticals Inc., A Viatris Company
Package NDC
0378-5815-77
Dosage Form
Tablet
Presentation
Valsartan, Tablet, 320 mg (NDC 0378-5815-77)
Initial Posting
Nov 19, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.